ClinicalTrials.gg
TerminatedNCT04978077Updated Dec 11, 2024

Networks of Bacterium-Metabolite Interactions in the Small Intestine

An interventional study of Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®) in Diet, Healthy and Microbial Colonization, sponsored by Insel Gruppe AG, University Hospital Bern. Terminated at 1 site in Switzerland. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-11.

Sponsored by Insel Gruppe AG, University Hospital Bern · Not applicable, Interventional, and Basic science

Why this study was terminated
The recruitment of the specific study population consisting of stoma patients proved escpecially difficult, so the recruitment was halted before the anticipated target number
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Probands with an Ileo- or Colostomy are assigned to consume a test meal which is either high in fat or high in carbohydrates. After the test meal samples from the stoma, urine, blood and skin are retrieved. These will be subjected to large scale analyses of microbiota and metabolite content. To get a better comparability test subjects will consume a standardized liquid diet three days before the study day.

Read the detailed description

Between both study days a two week wash out phase will be done. During the study day sampling will be done at set time points until 8 hours after the consumption of the test meal.

02

Conditions studied

  • Diet, Healthy
  • Microbial Colonization
03

In context

Communicable Diseases

4,448 studies on the registry are indexed under Communicable Diseases; 514 are open to participants now.

This study's enrollment of 120 is close to the median of 121 across 2,712 interventional studies indexed under Communicable Diseases.

Browse Communicable Diseases studies →

Lead sponsor

Insel Gruppe AG, University Hospital Bern is the lead sponsor of 737 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written informed consent
  • General good health
  • Ileostomy or colostomy

Exclusion criteria

Exclusion Criteria:

  • Hematologic disorders with contraindication of blood draw
  • Participation in other clinical trial interfering with study protocol
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    High fat test meal first, high carbohydrate test meal second

    Consumption of a high fat challenge first, consumption of a high carbohydrate challenge after two weeks wash out

    Other: Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)

  • Experimental
    High carbohydrate test meal first, high fat test meal second

    Consumption of a high carbohydrate challenge first, consumption of a high fit challenge after two weeks wash out

    Other: Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)

Interventions

  • OtherTest meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)

    After a night fast participants will drink the test meal

06

What researchers measure

Primary outcomes

  1. Identification of stimulating and inhibiting metabolite and bacteria interactions

    Correlation of results of secondary outcome measures to find interactions

    Time frame: 8 hours

  2. Reproduction of metabolite-bacteria interactions in vitro culture

    By culturing of bacteria with possible interactions together in vitro

    Time frame: 2 weeks

Secondary outcomes

  1. Analysis of bacteria species composition

    by 16S rRNA sequencing of sample content

    Time frame: 8 hours

  2. Cultivation of bacterial strains in various conditions including ileal fluids

    Cultivation of native species found in samples, as well as dedicated E. coli with recording capacity for transcriptional changes

    Time frame: 2 weeks

  3. Metabolite composition in intestinal fluids

    by untargeted mass spectrometry

    Time frame: 8 hours

  4. Metabolite composition in blood

    by untargeted mass spectrometry

    Time frame: 8 hours

  5. Metabolite composition in urine

    by untargeted mass spectrometry

    Time frame: 8 hours

  6. Metabolite composition in intestinal fluids, blood and urine

    by untargeted mass spectrometry

    Time frame: 8 hours

  7. Analyze eucaryotic and viral microbiome composition

    by shotgun sequencing of sample content

    Time frame: 8 hours

  8. Analysis of microbiota metabolic potential

    by shotgun sequencing of sample content

    Time frame: 8 hours

  9. Analysis of microbiota metabolic activity

    by sequencing of transcriptome of sample content

    Time frame: 8 hours

  10. Analysis of microbiota biomass

    by measuring absolute bacteria counts by flow cytometry of 16S spiking

    Time frame: 8 hours

07

Study locations

1 site
  • Inselspital
    Bern, 3010, Switzerland
08

References and documents

Individual participant data

Plan to share: Yes — Sequencing data will be shared in a public repository

Time frame: upon publication of study results open ended

Access criteria: public access

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2021 to primary completion in Nov 2024, 35 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 12, 2021
First posted
Jul 27, 2021
StartActual
Dec 16, 2021
Primary completionActual
Nov 30, 2024
CompletionActual
Nov 30, 2024
Last update
Dec 11, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04978077
Responsible party
Sponsor
First posted
Jul 27, 2021
Start date
Dec 16, 2021
Primary completion
Nov 30, 2024
Completion
Nov 30, 2024
Last update
Dec 11, 2024

Study contacts

Benjamin Misselwitz, Prof. Dr. med.
principal investigator · University Clinic for Visceral Surgery and Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion